Drug Approval | August 28, 2022
Cipla receives 6 observations from USFDA for Goa facility
There are no data integrity (DI) observations.
There are no data integrity (DI) observations.
The drive also conducted a mega health camp, cancer screening for women and men, ENT screening for children, and blood donation drive
The ninth acquisition since 2018
With the receipt of the EIR, the inspection stands successfully closed.
Lutio has the potential to offer significant cost savings when available to UK patients.
Desvenlafaxine Extended-Release Tablets, 25 mg is a generic equivalent of Pristiq Extended-Release Tablets, 25 mg of PF PRISM C.V.
Granules now have a total of 51 ANDA approvals from US FDA (49 Final approvals and 2 tentative approvals).
The company has received 1 (ONE) observation on Form 483 with respect to ANDA filed for the product to be manufactured at the said Facility.
This Bioforum will provide the latest insights on delivering increased speed, greater flexibility and enhanced quality while reducing the cost, and risks of navigating the evolving biopharma landscape
The initiative aims to reach out to more than 20 million people across the country and a number of social media influencers have also pledged to extend their whole-hearted support for the noble cause
Subscribe To Our Newsletter & Stay Updated
